▲ Syringes confiscated during a crackdown are displayed at a briefing on the results of the first special inspection into the hoarding of syringes, held at the Seoul Regional Food and Drug Administration on April 24.
With reports indicating that the United States and Iran have reached an agreement on a roadmap to end the war, the South Korean government has determined that disruptions to the domestic supply of medical products caused by the conflict have been largely resolved.
The Ministry of Health and Welfare held the "12th Meeting on Response to the Middle East War" today (June 16) with 12 health and medical organizations, including the Korean Medical Association and the Korean Hospital Association, to conduct a final review of the on-site supply status of medical products following the war.
During the meeting, the government and industry representatives assessed that the domestic distribution of medical products is returning to pre-war levels.
Since the outbreak of the war, the government has implemented various emergency measures, including diversifying raw material supply chains, issuing notices to prohibit hoarding, and stabilizing logistics and distribution networks.
Stock levels of medical products in the field have also reached a stable trajectory.
A survey conducted by the Health Insurance Review and Assessment Service on hospital-level medical institutions regarding the inventory of eight major medical products, including syringes, confirmed that stock levels are being maintained at a high range of 95% to 114% compared to the previous year.
(Photo: Yonhap News)
※ Please note: This article was translated by AI and may contain errors.